Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo

Gail V W Johnson, Richard S Jope

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Oral administration of 0.3% aluminum (citrate or sulfate salt) for 4 weeks significantly elevated adenosine 3′, 5′-monophosphate (cyclic AMP) levels in rat cortex, hippocampus, striatum and cerebellum. The largest effect observed was a 60% increase in cortical cyclic AMP levels in rats administered aluminum sulfate. The effects of orally administered aluminum on guanosine 3′,5′-monophosphate (cyclic GMP) levels were less widespread. Dietary aluminum citrate only elevated cyclic GMP levels in the hippocampus, while aluminum sulfate caused significant increases in the cerebellum, hippocampus and striatum. Aluminum citrate administered i.c.v. (1 μmol, 2 weeks postadministration) elevated cyclic AMP levels in the cortex, but had no effect on cyclic GMP levels. Aluminum administered either orally or i.c.v. had no effect on in vivo acetylcholine levels. However, dietary aluminum citrate significantly reduced choline levels in the cortex, hippocampus and striatum. Aluminum administered i.c.v. had no effect on choline acetyltransferase activity or on high-affinity choline transport. These results indicate that: (1) the metabolism of cyclic AMP and of cyclic GMP are more sensitive to aluminum than are presynaptic cholinergic processes; (2) the metabolism of cyclic AMP is more sensitive to the effects of aluminum than is the metabolism of cyclic GMP; and (3) cortical cAMP metabolism is the most sensitive to the presence of aluminum. Possible consequences of elevated levels of cyclic nucleotides induced by aluminum in the brain are proposed.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalBrain Research
Volume403
Issue number1
DOIs
StatePublished - Feb 10 1987
Externally publishedYes

Fingerprint

Cyclic GMP
Aluminum
Cyclic AMP
Cholinergic Agents
Brain
Hippocampus
Choline
Cerebellum
Guanosine Monophosphate
Choline O-Acetyltransferase
Cyclic Nucleotides
Adenosine
Acetylcholine
Oral Administration
Salts
aluminum citrate
aluminum sulfate

Keywords

  • Acetylcholine
  • Adenosine 3′,5′-monophosphate (Cyclic AMP)
  • Adenosine 3′,5′-monophosphate (Cyclic GMP)
  • Aluminum

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo. / Johnson, Gail V W; Jope, Richard S.

In: Brain Research, Vol. 403, No. 1, 10.02.1987, p. 1-6.

Research output: Contribution to journalArticle

@article{7b06d2ba6dde41c4b0c9c866db0e5d4c,
title = "Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo",
abstract = "Oral administration of 0.3{\%} aluminum (citrate or sulfate salt) for 4 weeks significantly elevated adenosine 3′, 5′-monophosphate (cyclic AMP) levels in rat cortex, hippocampus, striatum and cerebellum. The largest effect observed was a 60{\%} increase in cortical cyclic AMP levels in rats administered aluminum sulfate. The effects of orally administered aluminum on guanosine 3′,5′-monophosphate (cyclic GMP) levels were less widespread. Dietary aluminum citrate only elevated cyclic GMP levels in the hippocampus, while aluminum sulfate caused significant increases in the cerebellum, hippocampus and striatum. Aluminum citrate administered i.c.v. (1 μmol, 2 weeks postadministration) elevated cyclic AMP levels in the cortex, but had no effect on cyclic GMP levels. Aluminum administered either orally or i.c.v. had no effect on in vivo acetylcholine levels. However, dietary aluminum citrate significantly reduced choline levels in the cortex, hippocampus and striatum. Aluminum administered i.c.v. had no effect on choline acetyltransferase activity or on high-affinity choline transport. These results indicate that: (1) the metabolism of cyclic AMP and of cyclic GMP are more sensitive to aluminum than are presynaptic cholinergic processes; (2) the metabolism of cyclic AMP is more sensitive to the effects of aluminum than is the metabolism of cyclic GMP; and (3) cortical cAMP metabolism is the most sensitive to the presence of aluminum. Possible consequences of elevated levels of cyclic nucleotides induced by aluminum in the brain are proposed.",
keywords = "Acetylcholine, Adenosine 3′,5′-monophosphate (Cyclic AMP), Adenosine 3′,5′-monophosphate (Cyclic GMP), Aluminum",
author = "Johnson, {Gail V W} and Jope, {Richard S}",
year = "1987",
month = "2",
day = "10",
doi = "10.1016/0006-8993(87)90115-6",
language = "English",
volume = "403",
pages = "1--6",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo

AU - Johnson, Gail V W

AU - Jope, Richard S

PY - 1987/2/10

Y1 - 1987/2/10

N2 - Oral administration of 0.3% aluminum (citrate or sulfate salt) for 4 weeks significantly elevated adenosine 3′, 5′-monophosphate (cyclic AMP) levels in rat cortex, hippocampus, striatum and cerebellum. The largest effect observed was a 60% increase in cortical cyclic AMP levels in rats administered aluminum sulfate. The effects of orally administered aluminum on guanosine 3′,5′-monophosphate (cyclic GMP) levels were less widespread. Dietary aluminum citrate only elevated cyclic GMP levels in the hippocampus, while aluminum sulfate caused significant increases in the cerebellum, hippocampus and striatum. Aluminum citrate administered i.c.v. (1 μmol, 2 weeks postadministration) elevated cyclic AMP levels in the cortex, but had no effect on cyclic GMP levels. Aluminum administered either orally or i.c.v. had no effect on in vivo acetylcholine levels. However, dietary aluminum citrate significantly reduced choline levels in the cortex, hippocampus and striatum. Aluminum administered i.c.v. had no effect on choline acetyltransferase activity or on high-affinity choline transport. These results indicate that: (1) the metabolism of cyclic AMP and of cyclic GMP are more sensitive to aluminum than are presynaptic cholinergic processes; (2) the metabolism of cyclic AMP is more sensitive to the effects of aluminum than is the metabolism of cyclic GMP; and (3) cortical cAMP metabolism is the most sensitive to the presence of aluminum. Possible consequences of elevated levels of cyclic nucleotides induced by aluminum in the brain are proposed.

AB - Oral administration of 0.3% aluminum (citrate or sulfate salt) for 4 weeks significantly elevated adenosine 3′, 5′-monophosphate (cyclic AMP) levels in rat cortex, hippocampus, striatum and cerebellum. The largest effect observed was a 60% increase in cortical cyclic AMP levels in rats administered aluminum sulfate. The effects of orally administered aluminum on guanosine 3′,5′-monophosphate (cyclic GMP) levels were less widespread. Dietary aluminum citrate only elevated cyclic GMP levels in the hippocampus, while aluminum sulfate caused significant increases in the cerebellum, hippocampus and striatum. Aluminum citrate administered i.c.v. (1 μmol, 2 weeks postadministration) elevated cyclic AMP levels in the cortex, but had no effect on cyclic GMP levels. Aluminum administered either orally or i.c.v. had no effect on in vivo acetylcholine levels. However, dietary aluminum citrate significantly reduced choline levels in the cortex, hippocampus and striatum. Aluminum administered i.c.v. had no effect on choline acetyltransferase activity or on high-affinity choline transport. These results indicate that: (1) the metabolism of cyclic AMP and of cyclic GMP are more sensitive to aluminum than are presynaptic cholinergic processes; (2) the metabolism of cyclic AMP is more sensitive to the effects of aluminum than is the metabolism of cyclic GMP; and (3) cortical cAMP metabolism is the most sensitive to the presence of aluminum. Possible consequences of elevated levels of cyclic nucleotides induced by aluminum in the brain are proposed.

KW - Acetylcholine

KW - Adenosine 3′,5′-monophosphate (Cyclic AMP)

KW - Adenosine 3′,5′-monophosphate (Cyclic GMP)

KW - Aluminum

UR - http://www.scopus.com/inward/record.url?scp=0023092408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023092408&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(87)90115-6

DO - 10.1016/0006-8993(87)90115-6

M3 - Article

C2 - 3030501

AN - SCOPUS:0023092408

VL - 403

SP - 1

EP - 6

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -